stoxline Quote Chart Rank Option Currency Glossary
  
Co-Diagnostics, Inc. (CODX)
1.13  0.01 (0.89%)    02-27 16:00
Open: 1.15
High: 1.1694
Volume: 52,515
  
Pre. Close: 1.12
Low: 1.12
Market Cap: 35(M)
Technical analysis
2024-02-27 3:44:38 PM
Short term     
Mid term     
Targets 6-month :  1.45 1-year :  1.56
Resists First :  1.24 Second :  1.34
Pivot price 1.16
Supports First :  1.1 Second :  0.91
MAs MA(5) :  1.12 MA(20) :  1.17
MA(100) :  1.2 MA(250) :  1.33
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  22.7 D(3) :  17
RSI RSI(14): 41.9
52-week High :  3.09 Low :  0.97
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CODX ] has closed above bottom band by 32.8%. Bollinger Bands are 51.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.15 - 1.16 1.16 - 1.16
Low: 1.1 - 1.11 1.11 - 1.12
Close: 1.11 - 1.12 1.12 - 1.13
Company Description

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Headline News

Thu, 01 Feb 2024
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 - Nasdaq

Wed, 03 Jan 2024
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 - Yahoo Finance

Thu, 30 Nov 2023
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on ... - PR Newswire

Fri, 10 Nov 2023
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 09 Nov 2023
Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results - PR Newswire

Thu, 02 Nov 2023
Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 31 (M)
Shares Float 30 (M)
Held by Insiders 2.7 (%)
Held by Institutions 16.1 (%)
Shares Short 360 (K)
Shares Short P.Month 632 (K)
Stock Financials
EPS -1.39
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.24
Profit Margin 0 %
Operating Margin -363.7 %
Return on Assets (ttm) -20.3 %
Return on Equity (ttm) -36.4 %
Qtrly Rev. Growth -51.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.15
EBITDA (p.s.) -1.33
Qtrly Earnings Growth 0 %
Operating Cash Flow -21 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -0.83
PEG Ratio 0
Price to Book value 0.35
Price to Sales 7.48
Price to Cash Flow -1.64
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android